Showing results (171-180 of 217) with videos related to
Sort By:
Pageof 22
Cancer|December 15, 2023
Factors influencing parents' choice of palliative treatment goals for children with relapsed or refractory neuroblastoma: A multi-site longitudinal survey studyErica C Kaye, Jesse Smith, Yiwang Zhou, et al.Cancer|August 1, 2013
Neuroblastoma of undifferentiated subtype, prognostic significance of prominent nucleolar formation, and MYC/MYCN protein expression: a report from the Children's Oncology GroupLarry L Wang, Rie Suganuma, Naohiko Ikegaki, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2002
Treatment of high-risk neuroblastoma with triple-tandem high-dose therapy and stem-cell rescue: results of the Chicago Pilot II StudyMorris Kletzel, Howard M Katzenstein, Paul R Haut, et al.Cancer Letters|June 25, 2005
Epidural compression in neuroblastoma: Diagnostic and therapeutic aspectsBruno De Bernardi, Walentyna Balwierz, Joanna Bejent, et al.Pediatric Blood & Cancer|June 1, 2024
Long-term follow-up of patients with intermediate-risk neuroblastoma treated with response- and biology-based therapy: A report from the Children's Oncology Group study ANBL0531Erin K Barr, Arlene Naranjo, Clare J Twist, et al.JCO Precision Oncology|June 11, 2019
5-Hydroxymethylcytosine Profiles Are Prognostic of Outcome in Neuroblastoma and Reveal Transcriptional Networks That Correlate With Tumor PhenotypeMark A Applebaum, Erin K Barr, Jason Karpus, et al.Pediatric Blood & Cancer|November 6, 2024
Outcomes of patients with intermediate-risk neuroblastoma presenting with motor deficits relating to intraspinal tumor extension: A report from the Children's Oncology Group study ANBL0531Julie Voeller, Howard M Katzenstein, Arlene Naranjo, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 25, 2012
Outcome after surgery alone or with restricted use of chemotherapy for patients with low-risk neuroblastoma: results of Children's Oncology Group study P9641Douglas R Strother, Wendy B London, Mary Lou Schmidt, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 28, 2021
Revised Neuroblastoma Risk Classification System: A Report From the Children's Oncology GroupMeredith S Irwin, Arlene Naranjo, Fan F Zhang, et al.Cancer Research|July 21, 2012
Truncated DNMT3B isoform DNMT3B7 suppresses growth, induces differentiation, and alters DNA methylation in human neuroblastomaKelly R Ostler, Qiwei Yang, Timothy J Looney, et al.Pageof 22